Carlsmed, Inc.
CARL
$9.99
-$0.87-8.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.17M | 13.07M | 12.08M | 10.19M | 9.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.17M | 13.07M | 12.08M | 10.19M | 9.41M |
| Cost of Revenue | 3.56M | 3.15M | 3.21M | 2.55M | 2.38M |
| Gross Profit | 11.61M | 9.93M | 8.87M | 7.64M | 7.02M |
| SG&A Expenses | 15.66M | 14.52M | 11.21M | 10.21M | 8.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.48M | 22.11M | 18.59M | 15.91M | 14.11M |
| Operating Income | -9.32M | -9.04M | -6.50M | -5.72M | -4.70M |
| Income Before Tax | -8.61M | -8.53M | -6.77M | -5.73M | -4.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.61M | -8.53M | -6.77M | -5.73M | -4.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.61M | -8.53M | -6.77M | -5.73M | -4.72M |
| EBIT | -9.32M | -9.04M | -6.50M | -5.72M | -4.70M |
| EBITDA | -9.22M | -8.95M | -6.44M | -5.68M | -4.66M |
| EPS Basic | -0.32 | -0.40 | -1.47 | -1.47 | -1.14 |
| Normalized Basic EPS | -0.20 | -0.25 | -0.92 | -0.83 | -0.71 |
| EPS Diluted | -0.32 | -0.40 | -1.47 | -1.47 | -1.14 |
| Normalized Diluted EPS | -0.20 | -0.25 | -0.92 | -0.83 | -0.71 |
| Average Basic Shares Outstanding | 26.60M | 21.08M | 4.59M | 4.30M | 4.13M |
| Average Diluted Shares Outstanding | 26.60M | 21.08M | 4.59M | 4.30M | 4.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |